ContraFect Corporation(NASDAQ:CFRX) 
ContraFect Corporation, a clinical-stage biotechnology company, focuses on the discovery and development of therapeutic protein and antibody products for the treatment of life-threatening and drug-resistant infectious diseases in the United States. Its lead product candidates consist of CF-301, an i...
Website: http://www.contrafect.com
Founded: 2008
Full Time Employees: 24
Sector: Healthcare
Industry: Biotechnology
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2023-06-08
P
O 1.46
H 1.52
L 1.37
C 1.44
V 2,491,749
10EMA 1.44
20EMA 1.44
60EMA 1.44
120EMA 1.44
250EMA 1.44